Lab-cultured cardiac cells

Three types of human heart cells have been grown from cultures derived from embryonic stem cells, by a team of Canadian, US and UK scientists.

During the research, when a mix of the cells was transplanted into mice with simulated heart disease, the animals’ heart function was significantly improved, according to research published in the journal Nature.
The embryonic stem cell cultures were carefully supplied with a staged cocktail of growth factors and other molecules involved in development, and grew into immature versions of cardiomyocytes, endothelial cells and vascular smooth muscle cells, each important constituents of heart muscle. ‘This development means that we can efficiently and accurately make different types of human heart cells for use in both basic and clinical research, said researcher Dr Gordon Keller, of the McEwen Centre for Regenerative Medicine in Toronto. ‘The immediate impact of this is significant, as we now have an unlimited supply of these cells to study how they develop, how they function and how they respond to different drugs. In the future, the cells may also be very effective in developing new strategies for repairing damaged hearts, following a heart attack.’

30.04.2008

More on the subject:

Related articles

Photo

News • Standardized assessment criteria

Lost in translation: ICU experts call for universal severity score

Current scores to assess the severity of illness in ICU patients often fail in international contexts. Researchers now call for a global scoring system based on universally available data.

Photo

Product • Slide scanner system

Hamamatsu NanoZoomer® S540MD

The NanoZoomer S540MD by Hamamatsu is engineered with the lab in mind for a seamless workflow. Featuring compatibility with staining racks, fast slide scanning, exceptional image quality, and an…

Photo

News • New targetable driver of growth found

Thyroid gland: unexpected key to prostate cancer treatment

An international research team has discovered a promising new therapeutic approach for aggressive prostate cancer – in the thyroid gland.

Related products

Subscribe to Newsletter